Ipca Laboratories Limited
NSE: IPCALAB.NS0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- National Stock Exchange of India
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Pranay Premchand Godha
- Employees
- 17,335
- Headquarters
- Mumbai, India
- IPO year
- 1996
- Market cap
- ₹393.9B
- Website
- https://www.ipca.com
Loading IPCALAB…
Loading profile data…Frequently asked questions about IPCALAB
What does Ipca Laboratories Limited (IPCALAB.NS) do?
Ipca Laboratories Limited manufactures and markets pharmaceutical formulations and active pharmaceutical ingredients (APIs) for various therapeutic segments in India. It offers APIs in therapeutic areas of anti-hypertensive, anti-malarial, diuretic, DMARD, and anthelmintic. The company provides generic and branded formulations in the therapeutic...
Where does IPCALAB.NS trade?
Ipca Laboratories Limited (IPCALAB.NS) trades on the National Stock Exchange of India.
What sector is IPCALAB.NS in?
Ipca Laboratories Limited (IPCALAB.NS) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of Ipca Laboratories Limited?
Pranay Premchand Godha is the chief executive officer of Ipca Laboratories Limited (IPCALAB.NS).
Where is Ipca Laboratories Limited headquartered?
Ipca Laboratories Limited is headquartered in India.
Does IPCALAB.NS pay a dividend?
Yes — Ipca Laboratories Limited (IPCALAB.NS) paid a trailing twelve-month dividend of INR 4.00 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did IPCALAB.NS go public?
Ipca Laboratories Limited (IPCALAB.NS) completed its initial public offering in 1996.